Literature DB >> 1637681

Normal human breast xenografts activate N-nitrosodimethylamine: identification of potential target cells for an environmental nitrosamine.

S N Zaidi1, I Laidlaw, A Howell, C S Potten, D P Cooper, P J O'Connor.   

Abstract

Normal human breast tissue maintained as xenografts in female Balb/c (nu/nu) athymic mice is capable of metabolising N-nitrosodimethylamine (NDMA) to active intermediates that will react with DNA. Administration of NDMA to mice with slow-release implants of 17 beta-oestradiol which provide human physiological (luteal phase) circulating oestrogen levels and increase cell proliferation in the xenograft (Laidlaw et al., 1992), leads to an apparent increase in the extent of reaction with DNA compared to controls without oestrogen implants. In mice with oestrogen implants, measurements of the amounts of the promutagenic lesion, O6-methyl-2'-deoxyguanosine formed in DNA clearly indicated a dose related increase in the extent of reaction. Detection of O6-methyl-2'-deoxyguanosine using immunohistochemical procedures revealed that the nuclei of cells of the glandular epithelium, supportive tissue and adipose tissue, in decreasing order of prevalence, were positively stained for the presence of this DNA lesion. Epithelial cells, which are the putative target cells for carcinogenesis in the breast, are therefore prone to promutagenic damage as a result of exposure to an environmental nitrosamine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637681      PMCID: PMC1977899          DOI: 10.1038/bjc.1992.220

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Cell specific DNA alkylation in target and non-target organs of N-nitrosobis(2-oxopropyl)amine-induced carcinogenesis in hamster and rat.

Authors:  J Bax; C Schippers-Gillissen; R A Woutersen; E Scherer
Journal:  Carcinogenesis       Date:  1991-04       Impact factor: 4.944

2.  Phenobarbital: a non-genotoxic agent which induces the repair of O6-methylguanine from hepatic DNA.

Authors:  P J O'Connor; S Fida; C Y Fan; M Bromley; R Saffhill
Journal:  Carcinogenesis       Date:  1988-11       Impact factor: 4.944

3.  Levels of O6-methylguanine acceptor protein in extracts of human breast tumor tissues.

Authors:  E H Cao; X J Fan; X H Yuan; S M Xin; Y Y Liu; H T Yu
Journal:  Cancer Biochem Biophys       Date:  1991-06

4.  Promutagenic lesions persist in the DNA of target cells for nitrosamine-induced carcinogenesis.

Authors:  C Y Fan; W H Butler; P J O'Connor
Journal:  IARC Sci Publ       Date:  1991

5.  Exposure, susceptibility, and breast cancer risk: a hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence.

Authors:  N Krieger
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

6.  Promutagenic alkyl lesions are induced in the tissue DNA of animals treated with isoniazid.

Authors:  R Saffhill; S Fida; M Bromley; P J O'Connor
Journal:  Hum Toxicol       Date:  1988-07

7.  Isolation of deoxyribonucleic acid from mammalian tissues.

Authors:  K S Kirby; E A Cook
Journal:  Biochem J       Date:  1967-07       Impact factor: 3.857

8.  Identification in histological sections of species origin of cells from mouse, rat and human.

Authors:  G R Cunha; K D Vanderslice
Journal:  Stain Technol       Date:  1984-01

9.  The effect of age and menstrual cycle upon proliferative activity of the normal human breast.

Authors:  C S Potten; R J Watson; G T Williams; S Tickle; S A Roberts; M Harris; A Howell
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

10.  PLD-repair in human melanoma xenografts following single dose and fractionated irradiation.

Authors:  E K Rofstad
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

View more
  2 in total

Review 1.  Xenograft models of premalignant breast disease.

Authors:  F R Miller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

2.  TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution.

Authors:  Abeer J Al-Qasem; Mohamed Toulimat; Abdelmoneim M Eldali; Asma Tulbah; Nujoud Al-Yousef; Sooad K Al-Daihan; Nada Al-Tassan; Taher Al-Tweigeri; Abdelilah Aboussekhra
Journal:  Oncol Lett       Date:  2011-01-18       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.